Quantum-Si Incorporated - Ordinary Shares - Class A Stock News

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing.

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference.

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit.

Quantum-Si (QSI), a developer of next-generation protein sequencing technology, reported its Q2 2025 earnings on August 5, 2025. The most significant news was a steep revenue shortfall, as GAAP sales came in at $0.59 million compared to analyst estimates of $1.11 million—a miss of nearly 46.7%.

Quantum-Si incorporated (NASDAQ:QSI ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Jeffrey Alan Hawkins - President, CEO & Director Jeffry R. Keyes - CFO & Treasurer Risa Lindsay - Corporate Participant Conference Call Participants Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division Scott Robert Henry - Alliance Global Partners, Research Divisio...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Second Quarter 2025 Financial Results.